Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: A pilot study

Archives of Orthopaedic and Trauma Surgery

Volumn 129, Issue 3, 2009, Pages 417-423

  Conrozier, Thierry ^a   Jerosch, J ^b   Beks, P ^c   Kemper, F ^d   Euller Ziegler, L ^e   Bailleul, F ^f   Chevalier, X ^g  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b JOHANNA ETIENNE KRANKENHAUS   (Germany)

^c Gemeinschaftspraxis St Elisabeth ^*  (Germany)

^d Klinik St Marien   (Germany)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f Genzyme Europe BV   (Netherlands)

^g HENRI MONDOR HOSPITAL   (France)

Author keywords

Dosing; Hyaluronic acid; Hylan G F 20; Knee osteoarthritis; Viscosupplementation

Indexed keywords

HYALURONIC ACID DERIVATIVE; HYLAN G F 20; PARACETAMOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG DOSE COMPARISON; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; JOINT EFFUSION; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETREATMENT; SYMPTOM; SYNOVITIS; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ARTHRALGIA; BIOCOMPATIBLE MATERIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISCOSUPPLEMENTATION;

EID: 60449099952     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-008-0601-2     Document Type: Article

References (26)

1. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, Zummer M (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3:213-225
2. Altman R, Alarcon D, Appelrouth D, The American College of Rheumatology subcommittee on criteria for osteoarthritis (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505-511
3. Bagga H, Burkhardt D, Sambrook P, March L (2006) Long term effects of intra-articular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 33:946-950
4. Balazs EA (1958) Physical chemistry of hyaluronic acid. Fed Proc 17(4):1086-1093
5. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt WJ (1995) Validation of WOMAC. A health status instrument for measuring clinically important patient outcomes to rheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833-1840
6. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2:CD005321
7. Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L (2002) Hip osteoarthritis: Short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69:388-391
8. Conrozier T, Bertin P, Mathieu P, Charlot J, Bailleul F, Trèves R, Vignon E, Chevalier X (2003) Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: An open-label, multicentre, pilot study. Clin Exp Rheumatol 21:605-610
9. Conrozier T, Mathieu P, Schott AM, Laurent I, Hajri T, Crozes P, Grand P, Laurent H, Marchand F, Meignan F, Noel E, Rozand Y, Savoye JF, Vignon E (2003) Factors predicting long-term efficacy of hylan G-F 20 viscosupplementation in knee osteoarthritis. Joint Bone Spine 70:128-133
10. Dickson DJ, Hosie G (2001) A double blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 4:41-52
11. Felson DT (1990) The epidemiology of knee osteoarthritis: Results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum 20(3 (Suppl 1)):42-50
12. Goupille P, Hagena FW, Laprelle E, Goebel F, Noel E, Hardy P (2007) Prospective study of the safety and efficacy of hylan G-F 20 in symptomatic shoulder osteoarthritis. Poster presentation (P277) at the AAOS annual meeting, San Diego
13. Kahan A, LLeu PL, Salin L (2003) Prospective randomized study comparing the medicoeconomic benefits of hylan G-F 20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 70:276-281
14. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheum Dis 16:494-501
15. Kemper F, Gebhardt U, Meng T, Murray C (2005) Tolerability and short-term effectiveness of hylan G-F 20 in 4,253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 21:1261-1269
16. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R (1996) Viscosupplementation with hylan for the treatment of osteoarthritis: Findings from clinical practice in Canada. J Rheumatol 23:1579-1585
17. Pelletier JP, Martel-Pelletier J (1993) The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol 20(Suppl 39):19-23
18. Raynauld J-P, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N, Canadian Knee OA Study Group (2002) A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): Clinical results. Osteoarthritis Cartilage 10:506-517
19. Raynauld J-P, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P (2005) Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 13:111-119
20. Scale D, Wobig M, Wolpert W (1994) Viscosupplementation of osteoarthritic knees with hylan: A treatment schedule study. Curr Ther Res 55:220-232
21. Synvisc instructions for use (2006) Genzyme biosurgery
22. Tikiz C, Unlu Z, Sener A, Efe M, Tuzun C (2006) Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 24:244-250
23. Waddell DD, Cefalu CA, Bricker DC (2003) An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis. Curr Med Res Opin 19(6):499-507
24. Waddell DD, Bricker DC (2006) Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1,047 patients with osteoarthritis of the knee. J Knee Surg 19:19-27
25. Witteveen AGH, Giannini S, Guido G, Jerosch J, Lohrer H, van Dijk CN (2006) Prospective study of the safety and efficacy of hylan G-F 20 (Synvisc®) in patients with symptomatic ankle osteoarthritis. Poster presentation at the OARSI annual meeting, Prague
26. Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: A 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20:410-423